Literature DB >> 9864157

Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.

N Harada1, K Okajima, S Kushimoto, H Isobe, K Tanaka.   

Abstract

We investigated whether antithrombin (AT) can reduce ischemia/reperfusion (I/R)-induced injury of rat liver by promoting prostacyclin release from endothelial cells. Although intravenous administration of AT (250 U/kg) markedly reduced hepatic injury, neither dansyl-Glu-Gly-Arg-chloromethyl ketone-treated factor Xa (DEGR-Xa), a selective inhibitor of thrombin generation, nor Trp49-modified AT, which lacks affinity for heparin, had any effect. Hepatic levels of 6-keto-PGF1, a stable prostacyclin (PGI2) metabolite, were increased significantly after I/R of the rat liver. AT significantly increased the hepatic level of 6-keto-PGF1, whereas neither DEGR-Xa nor Trp49-modified AT increased it. Hepatic tissue blood flow was markedly reduced after I/R. Although AT significantly increased the hepatic tissue blood flow after I/R, neither DEGR-Xa nor Trp49-modified AT increased the blood flow. Hepatic levels of cytokine-induced neutrophil chemoattractant (CINC) and myeloperoxidase (MPO) were significantly increased after hepatic I/R. The levels of these two indicators were reduced by AT but were unaffected by either DEGR-Xa or Trp49-modified AT. Pretreatment of animals with indomethacin (IM) completely inhibited the protective effects of AT on the I/R-induced hepatic damage and the leukocyte activation as well as the AT-induced increase in hepatic 6-keto-PGF1 levels after I/R. Iloprost, a stable analog of PGI2, exhibited effects similar to those of AT and also significantly inhibited the exacerbation of liver injury, the decrease in hepatic tissue blood flow, and the increases in hepatic CINC and MPO levels seen in rats subjected to I/R but pretreated with IM. These findings suggest that AT may prevent I/R-induced hepatic injury by increasing the hepatic levels of PGI2 through the interaction of AT with cell-surface glycosaminoglycans, thus increasing hepatic tissue blood flow and inhibiting leukocyte activation in animals subjected to I/R.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864157

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

2.  The effects of glutamine on hepatic ischemia reperfusion injury in rats.

Authors:  S Sözen; M Kisakürek; F Yildiz; M Gönültaş; A S Dinçel
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

3.  Cardiovascular resistance to thrombosis in 13-lined ground squirrels.

Authors:  Alison Bonis; Leah Anderson; Gaëlle Talhouarne; Emily Schueller; Jenna Unke; Catherine Krus; Jordan Stokka; Anna Koepke; Brittany Lehrer; Anthony Schuh; Jeremiah J Andersen; Scott Cooper
Journal:  J Comp Physiol B       Date:  2018-10-13       Impact factor: 2.200

4.  Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury.

Authors:  Yina Ma; Jinli Wang; Junjie Gao; Hui Yang; Yanqing Wang; Chandrashekhara Manithody; Ji Li; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

5.  Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo.

Authors:  A Alvarez; L Piqueras; M A Blazquez; M J Sanz
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

6.  Antithrombin is protective against myocardial ischemia and reperfusion injury.

Authors:  J Wang; Y Wang; J Wang; J Gao; C Tong; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

7.  Protective effects of fish oil, allopurinol, and verapamil on hepatic ischemia-reperfusion injury in rats.

Authors:  Basim Anwar Shehata Messiha; Amira M Abo-Youssef
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

8.  A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Katherine Cianflone; Xiaoping Chen; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 9.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

10.  Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.

Authors:  Jorrit J Hofstra; Alexander D Cornet; Bart F de Rooy; Alexander P Vlaar; Tom van der Poll; Marcel Levi; Sebastian Aj Zaat; Marcus J Schultz
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.